Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Refractory Differentiated Thyroid Gland Carcinoma Clinical Trials

2 recruiting trials for Refractory Differentiated Thyroid Gland Carcinoma. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
2
Total Trials
2
Recruiting Now
1
Phase 3 Trials
2
Sponsors

Recruiting Trials

RECRUITINGPhase 3NCT06475989

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

This phase III trial compares the effect of cabozantinib versus combination dabrafenib and trametinib for the treatment of patients with differentiated thyroid cancer that does...

Sponsor: ECOG-ACRIN Cancer Research GroupEnrolling: 26420 locations
RECRUITINGPhase 2NCT06959641

XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer

This phase II trial tests how well XL092 works for the treatment of patients with differentiated thyroid cancer that has not responded to previous treatment with radioiodine...

Sponsor: Northwestern UniversityEnrolling: 331 location